Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C

Mona Prasad1, Grecio J Sandoval2, George R Saade3

  • 1Department of Obstetrics and Gynecology of the Ohio State University, Columbus, Ohio, USA.

Insights

A single hepatitis C virus (HCV) RNA test at 2-6 months accurately identifies perinatal HCV transmission. This sensitive and specific test ensures no cases requiring treatment are missed.

Area of Science:

  • Virology
  • Hepatology
  • Pediatric Infectious Diseases

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge.
  • Perinatal transmission of HCV from mother to child is a critical concern.
  • Accurate early identification of infant HCV infection is crucial for timely intervention.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of a single hepatitis C virus RNA test.
  • To determine the sensitivity and specificity of this test in identifying perinatal HCV transmission.
  • To assess the test's ability to detect cases requiring treatment.

Main Methods:

  • A study was conducted involving infants born to HCV-infected mothers.
  • A single hepatitis C virus RNA test was performed at 2-6 months of age.
  • Diagnostic performance metrics, including sensitivity and specificity with 95% confidence intervals (CI), were calculated.

Main Results:

  • The single HCV RNA test demonstrated high sensitivity (86.7%, 95% CI: 62.1%-96.3%) and specificity (100%, 95% CI: 98.8%-100%) for perinatal transmission.
  • The test successfully identified all cases of perinatal HCV infection that required treatment.
  • No cases of perinatal infection necessitating treatment were missed by the test.

Conclusions:

  • A single HCV RNA test at 2-6 months is a reliable tool for diagnosing perinatal HCV infection.
  • The high diagnostic accuracy supports its use in clinical settings for early detection.
  • This testing strategy can effectively identify infants who require further management for HCV.